Das Zentrum
Multiple Sklerose Zentrum Dresden
Patienteninformation
Kontaktinformation
Behandlungsteam
Studienteam
Neuropsychologie
Mobilitätszentrum
Das Mobilitätszentrum
Ganganalyse
Sprunganalyse
DIERS
EMIQ
Forschungsprojekte
Neuroimmunologisches Labor
Das NIL
Neurofilament-Leichtketten Analyse
Autonomes & Neuroendokrinologisches Funktionslabor
Das ANF
Untersuchungsmethoden
MS Living Lab
Management & Science
Team Management & Science
Projekte
eHealth & Analytics
MSDS 3D
MSDS Klinik & Praxis
MS-HRS
MTRS
MS Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
Deutsch
Deutsch
English (UK)
Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis
NIL
Jahr
Publikationsjahr
2023
Autoren
Autorenliste der Publikation
Ziemssen T, Schlegel E, Groth M, Ettle B, Bopp T.
Verlag
Publisher-Information
Vaccines (Basel). 2023 May 13;11(5):978.
Link
Zur Publikation (externer Server)
https://doi.org/10.3390/vaccines11050978
Tags
Forschungsthemen
Multiple Sklerose
Neuroimmunologie
NIL
2023
Neurofilaments as biomarkers in neurological disorders — towards clinical application
NIL
Jahr
2024
Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis Cohort
NIL
Jahr
2024
Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab
MS Treatments
Jahr
2024
Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance
NIL
Jahr
2024
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets
NIL
Jahr
2024
